What Have We Learned From The UK TAVI Registry? Simon Ray UHSM Manchester Academic Health Sciences Centre.

Slides:



Advertisements
Similar presentations
Quality of Cardiothoracic Surgical Care 2004 EACTS Clinical Database Initiatives: The European Adult Cardiac Surgical Database Bruce E. Keogh Chairman,
Advertisements

Trans-catheter Aortic Valve Implantation Should we all be doing this? Dr Philip MacCarthy BSc PhD FRCP Consultant Cardiologist King’s College Hospital,
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve ® has been approved. The CoreValve ® System is not currently approved in the USA,
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
When Does Baseline Left Ventricular Function Influence Survival Post Transcatheter Aortic Valve Implantation? —The CoreValve Australia New Zealand Study.
Chinese Association of Cardiovascular Surgeons 2007 Establishing a national cardiac surgical database: Insights from the UK & Europe Bruce E Keogh.
NDAU/NNAP Collaborators Meeting Neena Modi Professor of Neonatal Medicine Imperial College London Vice President, Science & Research Royal College of Paediatrics.
Does transparency improve quality? lessons learnt from cardiac surgery BCIS meeting 2006 Ben Bridgewater SMUHT.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
Two Cardiac Centres Are Better Than One Early Outcomes of the First 75 Open Heart Surgeries At Port of Spain General Hospital Randolph Rawlins M.B.B.S.,
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
Heart disease: Getting international collaboration right Chris Gale Associate Professor, Honorary Consultant Cardiologist University.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
B alloon-pump assisted C oronary I ntervention S tudy BCIS-1 Simon Redwood St Thomas’ Hospital / King’s College London On behalf of the BCIS-1 Investigators.
The Risk and Extent of Neurological Events Are Equivalent for High-Risk Patients Treated With Transcatheter or Surgical Aortic Valve Replacement Thomas.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Does Openness Improve Outcome ? The North-West Quality Improvement Program Dr R H Stables Cardiothoracic Centre Liverpool.
PRIMARY PCI - MAKING IT HAPPEN UK Proposals (BCS/DoH) Advanced Angioplasty 2005 Huon Gray Consultant Cardiologist, Southampton President, British Cardiac.
Monitoring the performance of cardiac surgeons Graeme L Hickey 1 ; Stuart W Grant 2 ; Camila Caiado 3 ; Iain Buchan 1 ; Ben Bridgewater 1,2 1 Northwest.
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
Axel Linke University of Leipzig Heart Center, Leipzig, Germany Sabine Bleiziffer German Heart Center, Munich, Germany Johan Bosmans University Hospital.
Aortic Stenosis -The Unmet Need Simon Ray University Hospitals of South Manchester ACI 2009.
How will we know whether this technology is appropriate? OR New procedures, NICE and Specialist Societies Bruce Campbell Chairman NICE Interventional Procedures.
GENDER DISPARITIES AMONG PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT Michael A. Gaglia, Jr.; Michael J. Lipinski; Rebecca Torguson; Jiaxiang.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
BCIS Autumn Meeting, Crewe, September 2008 Transcatheter Aortic Valve Intervention: How do we take it forward in the UK? Mark de Belder President, British.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
G. Michael Deeb, MD On Behalf of the US Pivotal Trial Investigators 3-Year Results From the US Pivotal High Risk Randomized Trial Comparing Self-Expanding.
Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
Incidence and Outcomes of Valve Hemodynamic Deterioration in Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: A Report from the Society.
Why have a national database? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester University and Manchester.
G. Michael Deeb, MD On Behalf of the CoreValve US Investigators
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve replacement for severe symptomatic aortic valve stenosis.
Patient Eligibility for Commercial TAVR in the US
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Late breaking news in heart valve disease
Jan L.Svennevig, MD,PhD Heart surgery in Norway 2009 Norwegian Association for Cardiothoracic Surgery Jan L.Svennevig, MD,PhD.
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)  Georg.
JAMA. 2014;312(2): doi: /jama Figure Legend:
MedStar Washington Hospital Center Cardiac Catheterization Conference
The Spanish Data Bank PEGASO M. Martínez-Sellés
30 Day Outcomes from the SOURCE XT TAVI Post Approval Study
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
NICOR A NICE Commissioned Pilot of Patient Reported Outcome Measures (PROMs) for Ablation of Cardiac Arrhythmias Withers KL 1, Patrick H 2, Cunningham.
Giuseppe Tarantini MD, PhD
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Harold L. Dauerman, MD; Michael J. Reardon,
Michael Mack, M.D. Dallas, TX February 21, 2010
Axel Linke University of Leipzig Heart Center, Leipzig, Germany
Annual Outcomes With Transcatheter Valve Therapy
One Year Outcomes in Real World Patients Treated with Transcatheter Aortic Valve Implantation The ADVANCE Study Axel Linke University of Leipzig Heart.
Balloon-Expandable Transcatheter Valve System : OUS Data
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
Is Open Heart Surgery Too Risky For You? Opt for a Minimally Invasive Procedure.
Annual Outcomes With Transcatheter Valve Therapy
Nat. Rev. Cardiol. doi: /nrcardio
Current UK and EACTS database initiatives
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Reply The Annals of Thoracic Surgery
Nat. Rev. Cardiol. doi: /nrcardio
Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease  Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve  Marjan Jahangiri, FRCS, Jean Claude Laborde,
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Presentation transcript:

What Have We Learned From The UK TAVI Registry? Simon Ray UHSM Manchester Academic Health Sciences Centre

NO CONFLICT OF INTEREST TO DECLARE

UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry Development –Collaborative program Professional Societies (BCIS and SCTS) Department of Health and Specialist Commissioners Health Technology Assessment and Regulators (NICE) –High quality data collection and analysis –Dataset developed and distributed in 2008 –Data collection via Central Cardiac Audit Database encrypted data sent centrally from all units to CCAD servers –Data entered prospectively

UK TAVI Dataset

100% of consecutive UK TAVI implants – 1 st Jan 2007 to 31 st Dec 2009 Mortality tracking – linkage of central TAVI database with the Office of National Statistics (ONS) 872 TAVI procedures – 862 successful valve implants, 10 unsuccessful UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry Data as Additional 43 cases from Belfast not included

UK TAVI Registry Demographics AllTransfemoralOther routes Male52% 54%p=ns Age median (IQR) yr83 (78-87) 83 (79-87)p=ns Age range (yr) Diabetes23% p=ns Prior CABG26%23%33%p=0.002 PVD32%23%51%p< CAD48%44%57%P< LMS disease5.6%4.6%8.0%p=ns Data as

UK TAVI Registry Casemix AllTransfemoralOther routes Peak AV gradient (mmHg)808277p=ns Valve Area (cm 2 ) p=ns LVEF>50%64%65%63%p=ns LVEF < 30%8%7%9%p=ns Logistic EURO Score21.6%20.3%24.5%P<0.01 Data as

UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry *41 subclavian, 2 other undeployed device in 10 cases Data as

UK TAVI Registry Casemix AllTransfemoralOther routes Angina43%44%39% Data as

UK TAVI Registry In Hospital Outcomes Other MACCEAllTransfemoralOther routes TIA0.6%0.3%1.1% Emergency Surgical AVR0.7%0%2.2% Breakdown 54 (6.2%) of patients died 88 (10.1%) died or had MI or CVA 10 died subsequent to CVA or MI 34 had CVA or MI and survived Data as

UK TAVI Centres Mortality tracking to Dec 31 st 2009 TAVI (intention to Rx) n=872 Mortality tracked n=842 Not tracked: life status reported at 1 year or discharge n=30 Not tracked Unknown outcome n=0 Survival curves based on n=872 Tracking

Data as /76/121 yr18/122 yr Survival: Transfemoral94.8%86.5%82.4%80.4%78.3% Number at risk Survival: Other routes89.1%79.6%75.5%71.1%66.5% Number at risk Other Transfemoral p=0.017 UK TAVI Registry 2 cases route unknown

Proctored case Unproctored case p=n.s. First 20 cases Subsequent cases p=n.s. Data as UK TAVI Registry Minimising the learning curve?

UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry Data as 22/12/10N=1472 French Registry N=244, German Registry N=697

Data Submission Timeline

UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry

UK TAVI Registry What Have We Learned? Successful implementation of a National dataset –UK wide data collection –All procedures prospectively captured –Incorporates complete experience of all centres including the proctored learning curves –Collaboration between all involved –Mortality tracking Encouraging early results In hospital mortality: 6.2% 30/7 mortality: 6.9% 1 yr mortality: 19.7%

UK TAVI Registry What Have We Learned? Highlights substantial inequality of commissioned activity Continuing postcode lottery Substantial numbers of patients have no access to a proven treatment

UK TAVI Registry Acknowledgements – Steering group Data Oversight Group: Mark de Belder, Ben Bridgewater, David Cunningham, Peter Ludman, Neil Moat Chair: Huon Gray Cardiologists Andreas Baumbach Mark de Belder Tony Gershlick David Hildick-Smith Jan Kovac Peter Ludman Phil MacCarthy Michael Mullen Simon Ray Martyn Thomas William Toff National Institute for Clinical Excellence Hannah Patrick Cardiothoracic surgeons Neil Moat Uday Trevidi Olaf Wendler Chris Young Central Cardiac Audit Database (CCAD) David Cunningham Specialist commissioners Tim Daniel Su Sethi Department of Health Roger Boyle Sue Dodd